Ramis Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 10-12-2024
- Paid Up Capital ₹ 2.51 Cr
as on 10-12-2024
- Company Age 17 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.38 Cr
as on 10-12-2024
- Satisfied Charges ₹ 14.77 Cr
as on 10-12-2024
- Revenue 17.71%
(FY 2022)
- Profit 25.54%
(FY 2022)
- Ebitda 1801.68%
(FY 2022)
- Net Worth 187.52%
(FY 2022)
- Total Assets 72.56%
(FY 2022)
About Ramis Laboratories
The Corporate was formerly known as Bondbay Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.51 Cr.
The company currently has active open charges totaling ₹22.38 Cr. The company has closed loans amounting to ₹14.77 Cr, as per Ministry of Corporate Affairs (MCA) records.
Venkata Goli and Sridhara Gandra serve as directors at the Company.
- CIN/LLPIN
U24232TG2007PTC055590
- Company No.
055590
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ramis Laboratories Private Limited offer?
Ramis Laboratories Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API Intermediate, Organic and Inorganic Solvents, Aromatic Hydrocarbon Solvent, Catalysts, Platinum Catalysts, Chemical Preservatives, API (Active Pharmaceutical Ingredients), Pharmaceutical Pellets, Imatinib Intermediates.
Who are the key members and board of directors at Ramis Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Goli  | Director | 19-Sep-2007 | Current |
| Sridhara Gandra | Director | 20-Apr-2010 | Current |
Financial Performance of Ramis Laboratories.
Ramis Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.71% increase. The company also saw a substantial improvement in profitability, with a 25.54% increase in profit. The company's net worth Soared by an impressive increase of 187.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ramis Laboratories?
In 2022, Ramis Laboratories had a promoter holding of 91.22% and a public holding of 8.78%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Dec 2023 | ₹20.43 Cr | Open |
Axis Bank Limited Creation Date: 19 Oct 2023 | ₹5.70 M | Open |
Karnataka Bank Ltd. Creation Date: 28 Feb 2022 | ₹1.00 Cr | Open |
How Many Employees Work at Ramis Laboratories?
Unlock and access historical data on people associated with Ramis Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ramis Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ramis Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
